The FDA) has approved Bio-T-Gel, which is licensed by BioSante to Teva Pharmaceuticals USA, Inc. Bio-T-Gel is a testosterone gel...
Allergan plc announced that the Company has received approval from the FDA to market Aczone (dapsone) Gel, 7.5%, a new...
Valeant Pharmaceuticals International, Inc. has announced that it has received approval from the FDA for Onexton Gel (clindamycin phosphate and...
KLOX Technologies has received CE mark approval in Europe for the topical photo-converter gel component in its LumiCleanse system, a...
Galderma announced that it has received a Positive Opinion from 16 concerned European regulatory agencies for the market approval of...
Sol-Gel Technologies, Ltd. announced an update regarding the FDA approval process for Epsolay (benzoyl peroxide) 5% topical cream for the treatment of Inflammatory lesions of rosacea in adults. In September of 2020, Sol-Gel was informed by the FDA that the PDUFA goal date for Epsolay is April 26, 2021.
Endo International plc has announced that it has introduced the first and only generic 2% topical testosterone gel, an authorized...
The injectable ACTH gel medication Cortrophin Gel (repository corticotropin injection), first introduced in the U.S. in the 1950s, will now be relaunched by ANI Pharmaceuticals as a treatment for acute flare-ups in multiple sclerosis (MS) and other autoimmune conditions, following its approval by the FDA.
Next Science receives CE Mark approval for BlastX wound gel. This approval allows Next Science to apply to sell BlastX in each market in the European Union and the UK.
Galderma Laboratories announced that the FDA approved antibiotic-free Epiduo Forte (adapalene and benzoyl peroxide) Gel, 0.3%/2.5%, for the once-daily, topical...